Abstract:The fermentation of non-digestible carbohydrates produces short-chain fatty acids (SCFAs), which have been shown to impact both skeletal muscle metabolic and inflammatory function; however, their effects within the obese skeletal muscle microenvironment are unknown. In this study, we developed a skeletal muscle in vitro model to mimic the critical features of the obese skeletal muscle microenvironment using L6 myotubes co-treated with 10 ng/mL lipopolysaccharide (LPS) and 500 μM palmitic acid (PA) for 24 h ± individual SCFAs, namely acetate, propionate and butyrate at 0.5 mM and 2.5 mM. At the lower SCFA concentration (0.5 mM), all three SCFA reduced the secreted protein level of RANTES, and only butyrate reduced IL-6 protein secretion and the intracellular protein levels of activated (i.e., ratio of phosphorylated–total) NFκB p65 and STAT3 (p < 0.05). Conversely, at the higher SCFA concentration (2.5 mM), individual SCFAs exerted different effects on inflammatory mediator secretion. Specifically, butyrate reduced IL-6, MCP-1 and RANTES secretion, propionate reduced IL-6 and RANTES, and acetate only reduced RANTES secretion (p < 0.05). All three SCFAs reduced intracellular protein levels of activated NFκB p65 and STAT3 (p < 0.05). Importantly, only the 2.5 mM SCFA concentration resulted in all three SCFAs increasing insulin-stimulated glucose uptake compared to control L6 myotube cultures (p < 0.05). Therefore, SCFAs exert differential effects on inflammatory mediator secretion in a cell culture model, recapitulating the obese skeletal muscle microenvironment; however, all three SCFAs exerted a beneficial metabolic effect only at a higher concentration via increasing insulin-stimulated glucose uptake, collectively exerting differing degrees of a beneficial effect on obesity-associated skeletal muscle dysfunction.

Short-chain fatty acids as potential regulators of skeletal muscle metabolism and function

The Athlete and Gut Microbiome: Short-chain Fatty Acids as Potential Ergogenic Aids for Exercise and Training

Exploring the relationship between gut microbiota and exercise: short-chain fatty acids and their role in metabolism

Gut microbiota-bile acid-skeletal muscle axis

Effect of Short-Chain Fatty Acids on Inflammatory and Metabolic Function in an Obese Skeletal Muscle Cell Culture Model

Microbial Regulation of Host Physiology by Short-chain Fatty Acids

Role of Gut Microbiota-Generated Short-Chain Fatty Acids in Metabolic and Cardiovascular Health

Short-Chain Fatty Acids and Human Health: From Metabolic Pathways to Current Therapeutic Implications

The role of short chain fatty acids in appetite regulation and energy homeostasis

The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism

Gut Microbiota and Short Chain Fatty Acids: Implications in Glucose Homeostasis

Role of short-chain fatty acids in host physiology

Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism

Short chain fatty acids in human gut and metabolic health

From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites

Mechanisms Involved in Gut Microbiota Regulation of Skeletal Muscle

Short-chain fatty acids in control of body weight and insulin sensitivity

Dietary Gut Microbial Metabolites, Short-chain Fatty Acids, and Host Metabolic Regulation

Skeletal muscles and gut microbiota-derived metabolites: novel modulators of adipocyte thermogenesis